Augmented ICOS signalling may contribute to the pathogenesis of Systemic Sclerosis (SSc) during early progressive disease. Soluble ICOS levels may be used as a serum marker for the activity and severity of SSc. Pub Med Rheumatology (Oxford). 2013 Feb;52(2):242-51. (Also see: Overview of B Cells and T Cells)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.